Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 1997

View Archived Issues

Use of desbutylhalofantrine for malaria claimed

ICE and apoptosis inhibitors disclosed by SmithKline Beecham

Antineoplastic cryptophycin compounds

Novel dopamine receptor ligands from Purdue Research Foundation/UNC

Lilly reports compounds for postmenopausal syndrome

Merck & Co. prepares cytokine inhibitors

Ibogamine congeners for addiction

Fluoxetine for the management of premature ejaculation

In vitro antitumor activity of lactoferrin

Mechanism of impaired erection with finasteride elucidated

Transurethral alprostadil/prazosin for erectile dysfunction

Nasacort now available for the treatment of allergic rhinitis

Moxisylyte recommended as first-line therapy for erectile dysfunction

Melanotropic peptide effective in men with erectile dysfunction

Initial clinical results with vinpocetine for urge incontinence

Nitrosylated alpha-adrenoceptor antagonists for erectile dysfunction

New COX-2 inhibitor from Searle

Nasal midazolam safe and effective for anterograde amnesia in children undergoing VCUG

DuPont Merck reports orally active acetylcholine release enhancer

Furosemide vs. placebo for nocturnal polyuria

TGF-beta1 antisense vaccine effective in rat prostate cancer model

GG-745 compared to finasteride in BPH patients

Natural interferon gamma introduced in Japan

Schering-Plough's Nasonex approved in U.K. and France

Norian seeks FDA approval for orthopedic applications of Norian SRS

Faulding launches wound care line in Australia and New Zealand

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...